Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.30 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.30 |
| ▸ | MVD | P53602 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20261774 | 1.00 | PLA2G2A (0.39) | PLA2G2ACYP3A4TSHRCA2BTN3A1 | |
| SCHEMBL12638785 | 1.00 | PLA2G2A (0.39) | PLA2G2ACYP3A4TSHRCA2BTN3A1 | |
| SCHEMBL20261782 | 1.00 | PLA2G2A (0.39) | PLA2G2ACYP3A4TSHRCA2BTN3A1 | |
| SCHEMBL14802705 | 0.95 | CYP3A4 (0.41) | PLA2G2ACYP3A4TSHRBTN3A1ALDH1A1 | |
| SCHEMBL19699812 | 0.95 | CYP3A4 (0.41) | PLA2G2ACYP3A4TSHRBTN3A1ALDH1A1 | |
| SCHEMBL6352756 | 0.93 | BTN3A1 (0.38) | PLA2G2ATSHRCA2BTN3A1ALDH1A1 | |
| SCHEMBL20213370 | 0.91 | TSHR (0.41) | PLA2G2ACYP3A4TSHRCA2BTN3A1 | |
| SCHEMBL20213334 | 0.91 | TSHR (0.41) | PLA2G2ACYP3A4TSHRCA2BTN3A1 | |
| SCHEMBL20278340 | 0.87 | TSHR (0.41) | PLA2G2ACYP3A4TSHRBTN3A1ALDH1A1 | |
| SCHEMBL19912248 | 0.87 | CYP3A4 (0.45) | PLA2G2ACYP3A4TSHRBTN3A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026421-A1 | METHODS FOR CAPTURING LONG POLYNUCLEOTIDES FOR SEQUENCING SPECIFIC GENOMIC REGIONS | GENERATION BIOTECH, LLC (US) | 2024-01-25 | — | — | US | disclosed |
| US-11821023-B2 | Method for capturing long polynucleotides for sequencing specific gnomic regions | GENERATION BIOTECH, LLC (US) | 2023-11-21 | — | — | US | disclosed |
| US-20200390904-A1 | ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES AS RADIO-SENSITIZERS AND MRI AND/OR X-RAY CONTRAST AGENTS | UNIV LOUISVILLE RES FOUND INC (US) | 2020-12-17 | — | — | US | disclosed |
| WO-2019153677-A1 | NEW METHOD FOR VISUAL QUANTITATIVE DETECTION OF DUAL HEAVY METAL IONS | 中国农业大学 | 2019-08-15 | — | — | WO | disclosed |
| US-20180042849-A1 | COCHLEATES AND METHODS OF USING THE SAME TO ENHANCE TISSUE PENETRATION OF PHARMACOLOGICALLY ACTIVE AGENT | AQUARIUS BIOTECHNOLOGIES, INC. | 2018-02-15 | — | — | US | disclosed |
| US-9551028-B2 | Nucleic acid sequence analysis | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2017-01-24 | — | — | US | disclosed |
| US-9499859-B2 | Method for detecting a circularized DNA, and use of said method for detecting mutations | Bockelmann, Ulrich (FR) | 2016-11-22 | — | — | US | disclosed |
| US-20150167071-A1 | NUCLEIC ACID SEQUENCE ANALYSIS | PACIFIC BIOSCIENCES CALIFORNIA (US) | 2015-06-18 | — | — | US | disclosed |
| US-8921046-B2 | Nucleic acid sequence analysis | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2014-12-30 | — | — | US | disclosed |
| US-8853134-B2 | Microarrays of binary nucleic acid probes for detecting nucleic acid analytes | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2014-10-07 | — | — | US | disclosed |
| US-20130130323-A1 | PREVENTION AND ALLEVIATION OF STERIC HINDRANCE DURING SINGLE MOLECULE SYNTHESIS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| US-8313903-B2 | Binary DNA probe for fluorescent analysis of nucleic acids | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2012-11-20 | — | — | US | disclosed |
| US-20120264630-A1 | METHOD FOR DETECTING A CIRCULARIZED DNA, AND USE OF SAID METHOD FOR DETECTING MUTATIONS | BOCKELMANN, ULRICH (FR) | 2012-10-18 | — | — | US | disclosed |
| US-8198023-B2 | Prevention and alleviation of steric hindrance during single molecule nucleic acid synthesis by a polymerase | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2012-06-12 | — | — | US | disclosed |
| US-20120115736-A1 | NUCLEIC ACID SEQUENCE ANALYSIS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2012-05-10 | — | — | US | disclosed |
| US-20120040867-A1 | Microarrays of Binary Nucleic Acid Probes for Detecting Nucleic Acid Analytes | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2012-02-16 | — | — | US | disclosed |
| US-7939654-B2 | Platelet derived growth factor (PDGF) nucleic acid ligand complexes | GILEAD SCIENCES, INC. (US) | 2011-05-10 | — | — | US | disclosed |
| US-20100075328-A1 | IMMOBILIZED NUCLEIC ACID COMPLEXES FOR SEQUENCE ANALYSIS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2010-03-25 | — | — | US | disclosed |
| US-20100035269-A1 | PREVENTION AND ALLEVIATION OF STERIC HINDRANCE DURING SINGLE MOLECULE SYNTHESIS | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2010-02-11 | — | — | US | disclosed |
| US-20090176318-A1 | BINARY DNA PROBE FOR FLUORESCENT ANALYSIS OF NUCLEIC ACIDS | COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390904-A1 | ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES AS RADIO-SENSITIZERS AND MRI AND/OR X-RAY CONTRAST AGENTS | NCL, HNRNPA1, HNRNPR | PLA2G2A 3440/4885CYP3A4 4761/4885TSHR 2194/4885 |
| US-20180042849-A1 | COCHLEATES AND METHODS OF USING THE SAME TO ENHANCE TISSUE PENETRATION OF PHARMACOLOGICALLY ACTIVE AGENT | SLC10A1, SLC10A2, PCYT1A | PLA2G2A 910/4885CYP3A4 3727/4885TSHR 3476/4885 |
| US-20090176318-A1 | BINARY DNA PROBE FOR FLUORESCENT ANALYSIS OF NUCLEIC ACIDS | SSBP1, MDH1, SNRPE | PLA2G2A 4823/4885CYP3A4 833/4885TSHR 4060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.